Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using P4 Peptide to Augment Ex Vivo Phagocyte Function in Patients with Severe Community Acquired Pneumonia (CAP)

NCT03497962 is registered in ClinicalTrials.gov with Liverpool University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT03497962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03497962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using P4 Peptide to Augment Ex Vivo Phagocyte Function in Patients with Severe Community Acquired Pneumonia (CAP)
Lead sponsor
Liverpool University Hospitals NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
April 30, 2014
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia